ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 109 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,306,000 | +217.2% | 30,839 | +391.5% | 0.38% | +228.7% |
| Q2 2018 | $727,000 | -11.3% | 6,275 | -38.1% | 0.12% | -16.1% |
| Q1 2018 | $820,000 | -78.5% | 10,138 | -86.5% | 0.14% | -74.2% |
| Q4 2014 | $3,809,000 | +53.3% | 74,915 | +19.4% | 0.53% | +5.3% |
| Q3 2014 | $2,484,000 | -10.6% | 62,768 | -2.8% | 0.50% | -4.4% |
| Q2 2014 | $2,780,000 | +5.6% | 64,554 | -2.0% | 0.53% | +11.2% |
| Q1 2014 | $2,633,000 | +42.6% | 65,846 | -2.8% | 0.48% | +43.5% |
| Q4 2013 | $1,847,000 | – | 67,708 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |